{"nct_id":"NCT04390763","title":"Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)","status":"TERMINATED","status_verified_date":"2025-05","start_date":"2020-10-16","start_date_type":"ACTUAL","primary_completion_date":"2024-04-26","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}